scholarly journals The Impact of Processes of Care on Myocardial Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction: Observations From the CRISP-AMI Trial

2014 ◽  
Vol 38 (1) ◽  
pp. 25-31 ◽  
Author(s):  
W. Schuyler Jones ◽  
Robert M. Clare ◽  
Karen Chiswell ◽  
Divaka Perera ◽  
John K. French ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Infarct Size ◽  
Myocardial Infarct ◽  
Myocardial Infarct Size ◽  
St Segment Elevation ◽  
Processes Of Care ◽  
Segment Elevation Myocardial Infarction ◽  
St Segment ◽  
The Impact

Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction

Heart ◽  
2013 ◽  
Vol 99 (20) ◽  
pp. 1525-1529 ◽  
Author(s):  
Sebastian Johannes Reinstadler ◽  
Gert Klug ◽  
Hans-Josef Feistritzer ◽  
Agnes Mayr ◽  
Bettina Harrasser ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Infarct Size ◽  
Myocardial Function ◽  
Myocardial Infarct ◽  
Myocardial Infarct Size ◽  
St Segment Elevation ◽  
Segment Elevation Myocardial Infarction ◽  
St Segment

scholarly journals New Interventional Therapies beyond Stenting to Treat ST-Segment Elevation Acute Myocardial Infarction

2021 ◽  
Vol 8 (9) ◽  
pp. 100
Author(s):  
Pablo Vidal-Calés ◽  
Pedro L. Cepas-Guillén ◽  
Salvatore Brugaletta ◽  
Manel Sabaté
Keyword(s):  
Myocardial Infarction ◽  
Infarct Size ◽  
Ischemia Reperfusion Injury ◽  
Myocardial Infarct ◽  
Ischemia Reperfusion ◽  
Myocardial Damage ◽  
Left Ventricular ◽  
Myocardial Infarct Size ◽  
St Segment Elevation ◽  
St Segment

Myocardial infarction remains the principal cause of death in Europe. In patients with ST-segment-elevation myocardial infarction (STEMI), a promptly revascularization with primary percutaneous intervention (PCI) has transformed prognosis in the last decades. However, despite increasing successful PCI procedures, mortality has remained unchanged in recent years. Also, due to an unsatisfactory reperfusion, some patients have significant myocardial damage and suffer left ventricular adverse remodeling with reduced function—all that resulting in the onset of heart failure with all its inherent clinical and socioeconomic burden. As a consequence of longer ischemic times, distal thrombotic embolization, ischemia-reperfusion injury and microvascular dysfunction, the resultant myocardial infarct size is the major prognostic determinant in STEMI patients. The improved understanding of all the pathophysiology underlying these events has derived to the development of several novel therapies aiming to reduce infarct size and to improve clinical outcomes in these patients. In this article, based on the mechanisms involved in myocardial infarction prognosis, we review the new interventional strategies beyond stenting that may solve the suboptimal results that STEMI patients still experience.

Sign in / Sign up

Export Citation Format

Share Document